Lantus Insulin

G e ne ric na m e T rad e n am e Class ifica tion insulin glarg ine L antus horm one s

Route SQ

T im e/Frequ en cyNorm al Do sa ge - 10 units the n 2-1 00 daily units

In dications-O nce-d aily treatm ent of diabe tes m ellitus. Con traindication s/w a rnings /interaction - allerg s y; stress ; C ontrol of bloo d gluco se in d iabetic patients pre gnancy; infec tio n; re nal/hep atic im p airme nt (may decrease insulin req uirem ents); G eriatric patie nts; Children. M echanism of ac tionLower b lood g lucose by Com m on side effec ts-Hypo glycem ia; lipodystrophy (lipoatrophy stim ulating g lucose uptake in skeletal m uscle and fat, and lip ohypertro py); pruritus; rash; allergic reactions inhib iting hep atic glucose p rod uction. La b v alue alterationsD ecrease serum and inorganic p hosp hate, mag nesium and p otassium levels. Nursin g Con sid erationTake svitals; sym pto m s of hypo glycem ia and hyperglycemia. Monitor bod y we ight period ically In terac tio ns w ith othe r patient drug s, O T C, or h erbal m edicines-Be ta blockers; c lo nidine; rese rpine ; Thiazid e Why E va luation-Control of blood diuretics; corticosteroids; d anazol; diltiaze m; dobutam ine;w ould you hold o r n ot give glucose le vels without the thyroid preparations; estro gens; isoniazid; nicotine; th is m ed?Hypog lyc em ia ap pearance of hyp oglyce mic or phenothiazines; p rogesterone; protease inhibitor; hyp erglyce mic ep isode s antriretrovirals; som atropin; thyroid ho rm o nes; sym patho mem etic age nts; rifamp in; testostero ne; alcohol; A C E inhibitors; clofb rate ; disopyram id e; fluo xe tine; MA O Is; NSA IDS ; octreo tid e; oral hypo glycemic agents; propoxyphene; sulfinpyraxozone; salicylate s; tetracyclines ; phe nylbutazone; warfarin.